Search

everythinglearnresearchcommunity

for

Search:↓

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

EGFR inhibitors for lung cancer can cause severe skin issues.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Abrocitinib may effectively treat stubborn alopecia universalis.

Tadalafil and Finasteride may help treat aggressive melanoma.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

CS12192 effectively treats alopecia areata with better safety than current options.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

TB and BCC tumors show similar follicular differentiation patterns.